ArticleFrontiers in oncology2022

IDO Inhibitor and Gallic Acid Cross-Linked Small Molecule Drug Synergistic Treatment of Melanoma.

Hongmei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.